enVVeno Medical Corporati...

NASDAQ: NVNO · Real-Time Price · USD
4.52
0.02 (0.44%)
At close: Aug 15, 2025, 9:45 AM

enVVeno Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-21.82M -23.52M -24.67M -16.53M
Depreciation & Amortization
528K 546K 525K 452.91K
Stock-Based Compensation
4.14M 5.2M 8.99M 6M
Other Working Capital
290K -395K -218K -312.1K
Other Non-Cash Items
22K -468K -339K -312.61K
Deferred Income Tax
n/a n/a n/a -312.7K
Change in Working Capital
290K -616K -130K -1.14M
Operating Cash Flow
-16.84M -18.86M -15.62M -11.85M
Capital Expenditures
-37K -33K -115K -367.89K
Cash Acquisitions
n/a n/a 34.44K n/a
Purchase of Investments
-55.57M -56.52M -48.13M n/a
Sales Maturities Of Investments
56.94M 48.69M 13.69M n/a
Other Investing Acitivies
n/a n/a -34.44K n/a
Investing Cash Flow
1.33M -7.87M -34.55M -367.89K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
46K n/a n/a 244.89K
Financial Cash Flow
13.64M 25.79M n/a 57.61M
Net Cash Flow
-1.87M -935K -50.17M 45.39M
Free Cash Flow
-16.88M -18.89M -15.73M -12.21M